Singapore, April 24, 2008: TCG Lifesciences Limited, a leading life sciences contract research services and informatics organization enabling translational medicine approach headquartered in India, has appointed Dr Bernd Sundermann as an Associate Vice President, Pre-clinical R&D, for looking after its business interests in Europe and European Union.

 

Prior to joining TCG Lifesciences, Dr Sundermann, was Head of Drug Discovery at Grunenthal GmbH in Aachen, Germany. At Grunenthal, he has over the years served in a variety of functions with responsibilities spanning across the drug discovery value chain. With the goal to create first-in-class NCEs Dr Sundermann has worked continuously on the interfaces with pharmacology, pharmacokinetics and toxicology. Dr Sundermann is a medicinal chemist by training and has more than a decade of experience in the fields of Drug Discovery and Pre-clinical Development and holds more than 75 global patents.

 

Mr Swapan Bhattacharya, Managing Director, TCG Lifesciences said, “Dr Sundermann’s track record and wide experience in Drug Discovery and Pre-clinical Development will not only help TCG Lifesciences in leveraging his excellent scientific skills but will also help strengthen our base in Europe & EU to serve our clients more effectively.”